Combination therapy incorporating Bcl ‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)

This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - October 24, 2017 Category: Hematology Authors: Wilson I. Gonsalves, Francis K. Buadi, Shaji K. Kumar Tags: Case Report Source Type: research